Company Overview and News

3
Dillard's Down 17% in 3 Months: Can Strategies Revive Stock?

2018-10-16 zacks
Shares of Dillard's, Inc. (DDS - Free Report) have lost 16.6% in the past three months due to the company’s soft cash flows, which has resulted in lesser share buybacks. Also, the company remains prone to challenging trends in the department store space due to the evolving retail trends, including e-commerce growth, which might dent its overall profitability. Meanwhile, the industry has declined 4.
DDS KSS M

1
Recent Analyst Upgrades Bring These 5 Stocks in Focus

2018-10-09 zacks
With the Q3 earnings season about to begin, investors look to add stocks that have the potential to surpass expectations. This is because an earnings beat generally leads to stock price appreciation.
VRSZQ DDS CASY VRSZ VRS ACM VRSZW

9
Costco (COST) Q4 Earnings: Solid Comps Run a Key Factor

2018-10-01 zacks
Costco Wholesale Corporation (COST - Free Report) is slated to report fourth-quarter fiscal 2018 results on Oct 4. In the last reported quarter, the company outperformed the Zacks Consensus Estimate by 1.2%. This Issaquah, WA-based company has outperformed the consensus mark in three of the trailing four quarters. Let’s see how things are shaping up prior to this announcement. Investors are keeping their fingers crossed and hoping for a positive earnings surprise from Costco in the quarter to be reported.
DDS 2454 SIG COST WBA SIG

52
Most Heavily Shorted Stocks Tank In September

2018-09-28 seekingalpha - 13
We published our regularly updated Short Interest Report earlier today in order to show clients which areas of the market are seeing the biggest increases and decreases in short interest levels. A supplement to the report is the table below highlighting the most heavily shorted stocks in the S&P 1500.
DDS MDXG MDCO AAOI ICHR

34
Zacks.com featured highlights include: Verso, Bed Bath, American Airlines, Avis Budget and Dillard's

2018-09-24 zacks
Chicago, IL – September 24, 2018 - Stocks in this week’s article are Verso Corp. (VRS - Free Report) , Bed Bath & Beyond Inc. (BBBY - Free Report) , American Airlines Group Inc. (AAL - Free Report) , Avis Budget Group Inc. (CAR - Free Report) and Dillard's Inc. (DDS - Free Report) .
VRSZQ DDS VRSZ VRS AAL VRSZW MCFT CAR LULU URI DXC.WI MBUU DXC BBBY TITN TLRD

16
Recent Analyst Upgrades Make These 5 Stocks Attractive

2018-09-21 zacks
With a deluge of stocks flooding the market at any point of time, investors might end up making a wrong choice while designing their portfolio in the absence of proper know-how.
VRSZQ DDS VRSZ VRS AAL VRSZW CAR BBBY

3
Investing In A Hated Sector - 13.6% Yield

2018-09-19 seekingalpha
Retail space is overbuilt and the e-commerce is stealing market share - a perfect combo for a disappear to happen.
DDS FB NFLX M

18
Only Time Will Tell: CBL Is A 'Strong Sell'

2018-09-14 seekingalpha - 1
"Do not underestimate how much the lack of funds could hamper their redevelopment efforts.” Beyond Savings.
SHLD DDS JCP COST DKS SHLDW BBBY

21
Zacks.com highlights: Delek US Holdings, ArcBest, Verso, DICK's Sporting Goods and Dillard's

2018-09-07 zacks
Chicago, IL – September 7, 2018 - Stocks in this week’s article include: Delek US Holdings, Inc. (DK - Free Report) , ArcBest Corporation (ARCB - Free Report) , Verso Corp. (VRS - Free Report) , DICK’S Sporting Goods Inc. (DKS - Free Report) and Dillard's Inc. (DDS - Free Report) .
ARLP VRSZQ CCR VRSZ VRSZW GLUU SHAK TPVZ LADR TPVY DKS GTIM GM JMP CVGI DDS VRS ARCB JMPB JMPC JMPD DK ALLY TPVG FG

3
5 Broker-Friendly Stocks to Counter Market Jitters

2018-09-07 investorplace
It is a well-documented fact that the U.S. economy is in good shape. Despite this, there are certain developments, which are keeping investors on the edge. While trade-related tensions with China continue to be a source of worry, President Trump’s threat to exclude Canada from a new NAFTA deal has also increased investor concern. Moreover, the ongoing troubles in emerging markets have also been a source of worry for investors.
DDS DK ARCB VRS DKS

3
Nordstrom Stock May Just Have Gotten a Little Too Hot

2018-09-07 investorplace
I never expected to be in this situation. The last time I discussed Nordstrom (NYSE:JWN), I did so as one name among several exciting retail plays. But just in a matter of days, Nordstrom stock jumped to double-digit gains. Having closed at a year-high of $65.02, what should investors expect next?
DDS JWN JCP M

6
5 Broker-Friendly Stocks to Counter Market Jitters

2018-09-06 zacks
It is a well-documented fact that the U.S. economy is in good shape. Despite this, there are certain developments, which are keeping investors on the edge. While trade-related tensions with China continue to be a source of worry, President Trump’s threat to exclude Canada from a new NAFTA deal has also increased investor concern. Moreover, the ongoing troubles in emerging markets have also been a source of worry for investors.
VRSZQ DDS VRSZ DK VRS ARCB KHC VRSZW

112
Tracking David Einhorn's Portfolio - Q2 2018 Update

2018-09-02 seekingalpha - 8
Greenlight's long/short ratio is at 96% long and 75% short compared to 111% long and 82% short last quarter.
TWX AZO MET BLMN DLTR TJX CEIX.WI SFM DSW CLPPZ AABA TWTR VNTR CLPR GLRE CNX.WI ADNT TWC XRX CNDT BHF ROKU GPS ATHN GRBK CCR MDCO NFLX PYPL HUN VOYA ESV ODP AAPL GM CEIX DDS XELA TPR TPX MU DG PRGO TSLA URBN FIVE CNX

307
Stocks To Watch: Time To Talk Valuation

2018-09-01 seekingalpha - 9
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
HIBB JWN DKS AVGO APRN PCB SODA AMC TMUS PDYPF AKCA JONE COUP SOLO REV MESA CZR LJPC VZ HEAR FCAU BRC MGM GCO FB ULTA IGT TM IRBT VCNX CTXR LB GMVHF MTCH DBX KS JNEEP AAPL USAK TSG ZAGG PRTY KSU DDS MRVL COOL HMC GBX TSCO DSKE MU DG WRK BYD LOW LRCX TXN CTRP TWX HA SKYW GNC RCL RH UAL PFCF AMZN TWTR CATO BKS VLKAY OSTK AAL BKE BBY GWRE MDLZ GME ON NSC NAV GOOGL QCOM HD XLNX CHDN CPB WDAY FND JBLU QSII WIMHY ALK ADBE MDXG GM GOGO CROX DAL CWH WIMHF F TECH PANW COST M SAVE WMH W S PEP URBN

1
Is Dillard's, Inc. (DDS) a Great Stock for Value Investors?

2018-08-28 zacks
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process.
ECR DDS LMHA LMHB LM

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 254067101